Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Analysis Group: London, GB

Manager
Employment
Source: Self-asserted source
Weiguang Xue

Works (6)

Association Between Event-Free Survival and Overall Survival in Early-Stage Triple-Negative Breast Cancer

Future Oncology
2024-02 | Journal article
DOI: 10.2217/fon-2023-0315
Contributors: Min Huang; Peter A Fasching; Amin Haiderali; Weiguang Xue; Wilbur Pan; Vassiliki Karantza; Fan Yang; James Truscott; Yiqiao Xin; Joyce O’Shaughnessy
Source: check_circle
Crossref

Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States

Journal of Medical Economics
2021-01-01 | Journal article
DOI: 10.1080/13696998.2020.1867470
Contributors: Beilei Cai; Zheng-Yi Zhou; Weiguang Xue; Nisha C. Hazra; Mukesh Singh; Dinesh Mishra; Diana Brixner; Gary Oderda; Joseph Biskupiak
Source: check_circle
Crossref

Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113

Journal of Medical Economics
2021-01-01 | Journal article
DOI: 10.1080/13696998.2021.1948230
Contributors: Weiguang Xue; Rinat Ribalov; Zheng-Yi Zhou; Rajeev Ayyagari; Sam Leo
Source: check_circle
Crossref

Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis

Journal of Cutaneous Medicine and Surgery
2020-11 | Journal article
DOI: 10.1177/1203475420933174
Contributors: Weiguang Xue; Paranjoy Saharia; Emma Gray; Shoghag Khoudigian-Sinani; Véronique Gaudet; Martin Barbeau; Kim Papp
Source: check_circle
Crossref

A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany

International Journal of Women's Health
2019-05 | Journal article
DOI: 10.2147/IJWH.S193048
Source: Self-asserted source
Weiguang Xue

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

ClinicoEconomics and Outcomes Research
2015-05 | Journal article
DOI: 10.2147/ceor.s82556
Part of ISSN: 1178-6981
Source: Self-asserted source
Weiguang Xue

Peer review (1 review for 1 publication/grant)

Review activity for PharmacoEconomics. (1)
How many people are using ORCID?